Skip to Content

Clinically and statistically significant improvement for efgartigimod in adults with ITP

In this MEDtalk dr. Catherine, Broome, associate, professor of Medicine at Med.Star Georgetown University Hospital in Washington, present the data of efficacy and safety for intravenous efgartigimod in adults with primary immune thrombocytopenia from the ADVANCE IV study, a multi-center double-blinded placebo controlled randomized clinical trial.

Catherine Broome

Get access to the article

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top